Navigation Links
Keryx Biopharmaceuticals, Inc. Prices Common Stock Offering
Date:5/4/2011

y Street, Suite 3700, San Francisco, California 94104, or by phone at (415) 364-2720.

ABOUT KERYX BIOPHARMACEUTICALS, INC.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease. Keryx is developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, and also affects a number of other key signal transduction pathways, including the JNK pathway, all of which are pathways associated with programmed cell death, cell growth, cell differentiation and cell survival. KRX-0401 has demonstrated both safety and clinical efficacy in several tumor types, both as a single agent and in combination with novel therapies. KRX-0401 is currently in Phase 3 clinical development for both refractory advanced colorectal cancer and multiple myeloma, and in Phase 1 and 2 clinical development for several other tumor types. Each of the KRX-0401 Phase 3 studies is being conducted under a Special Protocol Assessment (SPA) agreement with the Food and Drug Administration (FDA). Keryx is also developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. The Phase 3 clinical program of Zerenex in the treatment for hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease is being conducted pursuant to an SPA agreement with the FDA. Keryx is headquartered in New York City.

KERYX CONTACT:
Lauren Fischer
Director - Investor Relations
Keryx Biopharmaceuticals, Inc.
Tel: 212.531.5965
E-mail: lfischer@keryx.com


'/>"/>
SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Keryx Biopharmaceuticals Announces Commencement of Phase 3 Program of Ferric Citrate (Zerenex™) in Japan by Partner, Japan Tobacco and Torii Pharmaceutical
2. Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting
3. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2010 Financial Results
4. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year End 2010 Financial Results on Wednesday, March 9, 2011 at 8:30 a.m. ET
5. Keryx Biopharmaceuticals Announces Oral Presentation of Final Zerenex™ Short-Term Phase 3 Data at the Upcoming National Kidney Foundations 2011 Spring Clinical Meetings
6. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
7. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2010 Financial Results
8. Keryx Biopharmaceuticals Announces Completion of Patient Enrollment In Zerenex Phase 3 Short-Term Study
9. Keryx Biopharmaceuticals to Present at BioCenturys NewsMakers in the Biotech Industry Conference
10. Keryx Biopharmaceuticals to Present at JMP Securities Healthcare Conference
11. Keryx Biopharmaceuticals to Present at the 22nd Annual ROTH OC Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2014)... , Oct. 18, 2014  In a ... Campaign (HRC), the nation,s largest lesbian, gay, bisexual ... the use of Truvada for Pre-Exposure Prophylaxis (PrEP). ... used to prevent the spread of a disease ... only brand name anti-HIV drug combination currently approved ...
(Date:10/17/2014)... OAKS, Calif. , Oct. 17, 2014  Amgen ... of R. Sanders Williams , M.D., president of ... Mahley Distinguished Professor.  "We are pleased ... Amgen Board," said Robert A. Bradway , chairman ... and distinguished experience in academic medicine and his direct ...
(Date:10/17/2014)... October 17, 2014 ... Market by Technique (Optical Coherence Tomography, Hyperspectral ... Application (Ophthalmology, Neurology, Oncology, Cardiology) - Global ... studies the Optical Imaging market over the ... valued at $917.1 million in 2014 and ...
Breaking Medicine Technology:HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 2HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 3Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 3Optical Imaging Market Worth $1,669.2 Million by 2019 2Optical Imaging Market Worth $1,669.2 Million by 2019 3Optical Imaging Market Worth $1,669.2 Million by 2019 4
... pharmaceutical,company focused on the discovery and development of ... of microbial resistance,announces that its two most advanced ... four posters at the 19th European Congress of ... is,taking place in Helsinki between 16th and 19th ...
... --Gene Transfer Technology May Lead to an HIV Vaccine--PHILADELPHIA, ... the stubborn impasse that has frustrated the invention of ... bypasses the usual path followed by vaccine developers. By ... infection, the scientists protected monkeys from infection by a ...
Cached Medicine Technology:Novexel to Present Four Posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases in Helsinki 2Novexel to Present Four Posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases in Helsinki 3Novel Vaccine Approach Offers Hope in Fight Against HIV 2Novel Vaccine Approach Offers Hope in Fight Against HIV 3
(Date:10/20/2014)... 2014 hc1.com today announced the ... solution that enables healthcare organizations of all sizes ... customer relationship management (“CRM”) solution. , Designed from ... of the healthcare industry, the hc1 Healthcare Relationship ... patients by combining healthcare CRM, HIPAA-compliant collaboration, and ...
(Date:10/20/2014)... Dunbridge, Ohio (PRWEB) October 20, 2014 ... 50 years, takes pride in manufacturing top-of-the-line absorbent products. ... the image of its most popular brand, Tranquility® Premium ... logo, created a new website, gave its packaging a ... to bring the brand message to the public. , ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Succeed is proud ... local companies who participated in the Every Body Walk! ... a public awareness project that encourages workers to be more ... Step 10,000 Program, which concluded at the end of September, ... of cities and metro areas. Participating companies gave their ...
(Date:10/20/2014)... Unveiled at the Sept. 18 board meeting, The Center ... hospital ROI on membership dues at 12.5. In other words, ... in value to member hospitals. The calculation used to determine ... , “This is the first time we’ve actually been ... methodology is really sound,” said Bill Ryan , president ...
(Date:10/20/2014)... Silver Spring, Maryland, USA (PRWEB) October 20, 2014 ... readers or to track interventions? Here comes a wonderful ... leading mobile app development company helped its ... track Intervention more efficiently. The app is designed for ... iPad, and iPod touch. This app is optimized for ...
Breaking Medicine News(10 mins):Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3
... Imaging System and Companion C7 Dragonfly(TM) Imaging Catheter ... LightLab Imaging Inc., the pioneer and leader in ... vascular and other applications, today announced the launch ... System with the C7 Dragonfly Imaging Catheter, at ...
... heroes of fight against pediatric neuro-oncologyNEW YORK, May 13 ... this year,s 7th Annual Dream & Promise Awards Gala, ... Marquis in Times Square to support the Children,s Brain ... help kids with brain and spinal cord tumors and ...
... have neuropathy onset during their 30s-60sNEW YORK, May 13 ... neuropathy patients finds that the majority of respondents had ... with 82% experiencing neuropathy,s onset between the ages of ... affects all ages, all types of people," observes Tina ...
... Ill., May 13 It,s estimated that 4.7 ... Fortunately, most dog bites are preventable through appropriate ... control, and education of dog owners and potential ... joined with the U.S. Postal Service (USPS), the ...
... by Gearworks - will be on display and demonstrated at booth #118 ... May 14-16, 2009 in San Antonio, Tex. , ... Minneapolis, Minn. ... location-based mobile business applications, today announced its mobile health care solution -- ...
... Illinois has announced that Ginger Zee, Meteorologist for NBC5 Chicago, ... Award". The presentation will take place on Friday, May ... with Carmen". The awards ceremony, reception and buffet will ... the Chicago Opera Theater,s "La Tragedie de Carmen" at the ...
Cached Medicine News:Health News:LightLab Imaging Introduces World's Highest Resolution OCT System for Intracoronary Imaging at EuroPCR 2009 2Health News:Bonnie Hunt, Melina Kanakaredes and Dr. Ruth Westheimer Lend Their Support to Children's Brain Tumor Foundation Benefit 2Health News:Bonnie Hunt, Melina Kanakaredes and Dr. Ruth Westheimer Lend Their Support to Children's Brain Tumor Foundation Benefit 3Health News:Bonnie Hunt, Melina Kanakaredes and Dr. Ruth Westheimer Lend Their Support to Children's Brain Tumor Foundation Benefit 4Health News:Bonnie Hunt, Melina Kanakaredes and Dr. Ruth Westheimer Lend Their Support to Children's Brain Tumor Foundation Benefit 5Health News:First-Time National Poll Confirms Neuropathy Hits Millions in Their Prime 2Health News:First-Time National Poll Confirms Neuropathy Hits Millions in Their Prime 3Health News:First-Time National Poll Confirms Neuropathy Hits Millions in Their Prime 4Health News:National Dog Bite Prevention Week - Prevention is the Best Cure for Dog Bites 2Health News:National Dog Bite Prevention Week - Prevention is the Best Cure for Dog Bites 3Health News:National Dog Bite Prevention Week - Prevention is the Best Cure for Dog Bites 4Health News:National Dog Bite Prevention Week - Prevention is the Best Cure for Dog Bites 5Health News:Gearworks to Exhibit OnCare at VNAA 27th Annual Meeting 2Health News:Gearworks to Exhibit OnCare at VNAA 27th Annual Meeting 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: